What are the evidence‑based benefits of incentive spirometry for preventing postoperative atelectasis and pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evidence-Based Benefits of Incentive Spirometry

Primary Recommendation

Incentive spirometry alone provides no proven benefit over deep breathing exercises for preventing postoperative pulmonary complications, but when combined with multimodal respiratory care (deep breathing, early mobilization, supported coughing, adequate analgesia), it reduces atelectasis and pneumonia in high-risk surgical patients. 1, 2, 3

Demonstrated Benefits in High-Risk Populations

Reduction in Pulmonary Complications

  • Incentive spirometry as part of multimodal care reduces postoperative pneumonia risk by approximately 55-56% (risk ratio 0.44-0.45) in patients undergoing abdominal surgery 4

  • Atelectasis rates decrease by 41-47% (risk ratio 0.53-0.59) when incentive spirometry is combined with comprehensive respiratory physiotherapy 4, 3

  • In cardiac surgery patients receiving preoperative inspiratory muscle training with incentive spirometry devices, overall respiratory complications decreased from 27.3% to 10.2%, though pneumonia reduction (7.1% vs 3.1%) did not reach statistical significance in shorter protocols 4

Hospital Length of Stay

  • Hospital stay is reduced by 1-3.2 days when incentive spirometry is part of multimodal prehabilitation and postoperative care programs 4

  • The benefit is most pronounced when respiratory preparation includes at least 2-4 weeks of preoperative training with inspiratory pressure devices 4, 2

Patient Populations That Benefit Most

High-Risk Criteria (Strong Evidence)

  • Age >60 years - the strongest patient-related risk factor for postoperative pulmonary complications 1, 3

  • Chronic obstructive pulmonary disease - emerging evidence shows specific benefit in COPD patients when incentive spirometry is combined with smoking cessation, early mobilization, and effective analgesia 2, 5

  • ASA class II or higher, functional dependence, congestive heart failure 1, 3

  • Low serum albumin <35 g/L - one of the most powerful predictors of complications 1, 3, 6

High-Risk Surgical Procedures

  • Abdominal surgery (especially upper abdominal), thoracic surgery, head and neck surgery, vascular surgery, neurosurgery 1, 6

  • Prolonged surgery >3-4 hours (odds ratio 2.14) 3, 6

  • Emergency surgery (odds ratio 4.47) 3, 6

Optimal Implementation Protocol

Technique and Frequency

  • Perform 10 maximal inspiratory maneuvers every hour while awake, continuing for at least 2-4 weeks postoperatively 2

  • Patients must sit upright when using the device, taking slow deep breaths through the mouthpiece, holding for 3-5 seconds, then exhaling 2

  • Volume-oriented devices are preferred over flow-oriented devices 7

Essential Multimodal Components (Cannot Be Omitted)

  • Deep breathing exercises - provide equivalent benefit to incentive spirometry alone and are more labor-efficient 1, 2, 3

  • Early mobilization - patients should be out of bed on the day of surgery 2, 3

  • Supported coughing with incision splinting 3

  • Adequate pain control - essential to prevent ineffective use 2, 3

  • Selective (not routine) nasogastric tube use - routine placement significantly increases pneumonia and atelectasis rates 1, 3

When Incentive Spirometry Provides NO Additional Benefit

Cardiac Surgery Population

  • A 2012 Cochrane review of 592 CABG patients found no evidence of benefit from incentive spirometry compared to physical therapy alone, positive pressure breathing, or preoperative education 8

  • Adding incentive spirometry to comprehensive physiotherapy does not improve outcomes compared to multimodal care alone in coronary surgery patients 9, 8

  • Routine use after CABG is not recommended 7

General Thoracic Surgery

  • No demonstrated benefit in reducing postoperative pulmonary complications or hospital stay when added to standard thoracic expansion exercises, supported coughing, and early mobilization 2, 5

  • Exception: Higher-risk thoracic surgery patients with COPD may benefit when incentive spirometry is part of multimodal care 5

Superior Alternatives for Specific Situations

Hypoxemic Patients Unable to Perform Incentive Spirometry

  • CPAP or non-invasive positive pressure ventilation at 8-10 cm H₂O for 8-12 hours post-extubation is superior to standard oxygen therapy and incentive spirometry 2, 3

  • CPAP of 10 cm H₂O after thoracoabdominal surgery reduces ICU and hospital stay more effectively than incentive spirometry alone 6

Patients with Inadequate Effort or Adherence

  • Nasal continuous positive-airway pressure may be especially beneficial when patients cannot perform incentive spirometry or deep breathing exercises effectively 1

Critical Pitfalls to Avoid

  • Never use incentive spirometry as a standalone intervention - it must be part of multimodal care including deep breathing, mobilization, and adequate analgesia 2, 3, 7

  • Do not apply to low-risk patients - no evidence of benefit and wastes resources 2

  • Avoid routine nasogastric tube placement - selective use significantly reduces pneumonia compared to routine placement 1, 3

  • Do not delay early mobilization - mobilization is equally or more important than incentive spirometry 2, 3

  • Inadequate pain control renders incentive spirometry ineffective - optimize analgesia first 2, 3

  • Patient adherence is challenging - studies show difficulty achieving prescribed frequency, limiting real-world effectiveness 5, 9

Preoperative Optimization

  • Cardiorespiratory and muscular prehabilitation programs of at least 4 weeks preoperatively reduce postoperative complications (OR 0.52) and severe pneumonia (OR 0.40) 4

  • Inspiratory muscle training with adjustable pressure valve devices requires minimum 5 days of twice-daily practice, though 2-4 weeks is optimal 4, 2

  • Smoking cessation 4-8 weeks preoperatively is essential for COPD patients as part of multimodal care 2, 3

Related Questions

Is requiring incentive spirometry, EzPAP (positive airway pressure device), and Acapella (airway clearance device) for all patients breathing room air without a history of respiratory disease medically justified, or could it constitute Medicare fraud?
Can an incentive spirometer be used for chest physiotherapy after thyroidectomy?
What is the role of incentive spirometry (IS) in patients with a history of respiratory disease, cancer, or other conditions that may impact lung function after undergoing thoracentesis?
In a patient with an active pneumothorax, should an incentive spirometer be used?
Does using an incentive spirometer and walking decrease temperature in patients with respiratory conditions, such as Chronic Obstructive Pulmonary Disease (COPD) or pneumonia?
What are the possible causes and initial work‑up for generalized whole‑body tingling (paresthesia)?
What amount of weight gain does olanzapine cause and what monitoring and management strategies are recommended?
What are the differential diagnoses and initial emergency work‑up for a patient presenting with chest pain, dyspnea, fatigue, and generalized paresthesias?
Can a patient take valacyclovir for herpes simplex virus infection while being treated with cephalexin?
Can I add meloxicam to my current regimen of hydrocodone, amitriptyline, and pregabalin if I have no untreated peptic ulcer disease, no significant renal or hepatic impairment, no uncontrolled hypertension, and no known drug allergies?
In a treatment‑naïve adult with confirmed Helicobacter pylori infection, can Pyloricil (containing mastic gum, berberine, and bismuth) be used as the sole eradication therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.